| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Neurodevelopmental Disorders | 9 | 2024 | 462 | 1.710 |
Why?
|
| Intellectual Disability | 12 | 2024 | 1043 | 1.240 |
Why?
|
| Mitochondrial Diseases | 3 | 2024 | 135 | 1.120 |
Why?
|
| Leukoencephalopathies | 3 | 2020 | 54 | 0.960 |
Why?
|
| Genetic Testing | 2 | 2021 | 994 | 0.920 |
Why?
|
| Developmental Disabilities | 11 | 2024 | 695 | 0.910 |
Why?
|
| Neurology | 2 | 2023 | 108 | 0.860 |
Why?
|
| MELAS Syndrome | 6 | 2023 | 33 | 0.770 |
Why?
|
| Nervous System Malformations | 4 | 2024 | 126 | 0.700 |
Why?
|
| Genetic Counseling | 1 | 2021 | 222 | 0.680 |
Why?
|
| Mutation | 13 | 2024 | 5782 | 0.630 |
Why?
|
| Cerebral Palsy | 1 | 2020 | 79 | 0.620 |
Why?
|
| Microcephaly | 4 | 2024 | 328 | 0.600 |
Why?
|
| Musculoskeletal Abnormalities | 2 | 2019 | 73 | 0.600 |
Why?
|
| Phenotype | 17 | 2024 | 4218 | 0.570 |
Why?
|
| Autism Spectrum Disorder | 4 | 2023 | 374 | 0.560 |
Why?
|
| Chromosomes, Human, Pair 17 | 1 | 2018 | 371 | 0.550 |
Why?
|
| Hydrocephalus | 1 | 2018 | 236 | 0.530 |
Why?
|
| Genetic Association Studies | 5 | 2024 | 756 | 0.510 |
Why?
|
| Chromosome Deletion | 1 | 2018 | 638 | 0.500 |
Why?
|
| Citrulline | 5 | 2023 | 84 | 0.470 |
Why?
|
| Leukodystrophy, Metachromatic | 2 | 2024 | 5 | 0.470 |
Why?
|
| Lipoma | 1 | 2014 | 23 | 0.470 |
Why?
|
| Nevus | 1 | 2014 | 36 | 0.460 |
Why?
|
| Child, Preschool | 27 | 2024 | 13838 | 0.460 |
Why?
|
| Mitochondria | 4 | 2024 | 670 | 0.440 |
Why?
|
| Arginine | 5 | 2023 | 303 | 0.430 |
Why?
|
| Amniotic Fluid | 1 | 2014 | 147 | 0.430 |
Why?
|
| Vascular Malformations | 1 | 2014 | 81 | 0.430 |
Why?
|
| Ultrasonography, Prenatal | 1 | 2018 | 901 | 0.420 |
Why?
|
| Brain | 7 | 2024 | 2948 | 0.400 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2014 | 342 | 0.400 |
Why?
|
| Arginine-tRNA Ligase | 2 | 2024 | 9 | 0.400 |
Why?
|
| Mitochondrial Encephalomyopathies | 2 | 2023 | 27 | 0.390 |
Why?
|
| Child | 29 | 2024 | 24111 | 0.390 |
Why?
|
| Humans | 62 | 2024 | 122300 | 0.390 |
Why?
|
| Transcription Factors | 5 | 2023 | 2587 | 0.390 |
Why?
|
| Epilepsy | 5 | 2024 | 859 | 0.390 |
Why?
|
| Nitric Oxide | 4 | 2016 | 439 | 0.360 |
Why?
|
| Seizures | 7 | 2024 | 875 | 0.340 |
Why?
|
| Autistic Disorder | 3 | 2022 | 345 | 0.340 |
Why?
|
| Cerebellar Ataxia | 2 | 2021 | 65 | 0.320 |
Why?
|
| Genetic Predisposition to Disease | 4 | 2021 | 3073 | 0.320 |
Why?
|
| Genetic Variation | 3 | 2020 | 1476 | 0.310 |
Why?
|
| Male | 34 | 2024 | 59545 | 0.300 |
Why?
|
| Infant | 18 | 2024 | 12341 | 0.290 |
Why?
|
| Heterozygote | 4 | 2024 | 681 | 0.280 |
Why?
|
| Age of Onset | 3 | 2024 | 580 | 0.280 |
Why?
|
| Female | 34 | 2024 | 64911 | 0.280 |
Why?
|
| DNA-Binding Proteins | 3 | 2024 | 2041 | 0.270 |
Why?
|
| Nervous System Diseases | 3 | 2024 | 371 | 0.270 |
Why?
|
| Neurodegenerative Diseases | 2 | 2021 | 250 | 0.270 |
Why?
|
| Loss of Function Mutation | 2 | 2024 | 143 | 0.270 |
Why?
|
| Gain of Function Mutation | 2 | 2024 | 104 | 0.270 |
Why?
|
| Fibroblasts | 4 | 2024 | 882 | 0.260 |
Why?
|
| Alleles | 6 | 2023 | 1594 | 0.260 |
Why?
|
| Infant, Newborn | 7 | 2024 | 8113 | 0.250 |
Why?
|
| Siblings | 2 | 2024 | 193 | 0.250 |
Why?
|
| White Matter | 3 | 2022 | 181 | 0.240 |
Why?
|
| Genetic Diseases, Inborn | 2 | 2020 | 446 | 0.240 |
Why?
|
| Autoimmune Diseases of the Nervous System | 1 | 2024 | 30 | 0.230 |
Why?
|
| rab GTP-Binding Proteins | 1 | 2024 | 49 | 0.230 |
Why?
|
| Sequence Analysis, RNA | 2 | 2024 | 371 | 0.230 |
Why?
|
| Genomics | 2 | 2024 | 1472 | 0.230 |
Why?
|
| Receptors, AMPA | 1 | 2024 | 49 | 0.230 |
Why?
|
| Ectodermal Dysplasia | 1 | 2024 | 43 | 0.220 |
Why?
|
| Magnetic Resonance Imaging | 6 | 2021 | 3455 | 0.220 |
Why?
|
| Language Development Disorders | 2 | 2022 | 173 | 0.220 |
Why?
|
| Cell Transdifferentiation | 1 | 2024 | 67 | 0.220 |
Why?
|
| Acidosis, Lactic | 1 | 2023 | 30 | 0.220 |
Why?
|
| Paraparesis, Spastic | 1 | 2023 | 4 | 0.220 |
Why?
|
| Adolescent | 17 | 2024 | 18979 | 0.220 |
Why?
|
| Hereditary Central Nervous System Demyelinating Diseases | 2 | 2020 | 17 | 0.220 |
Why?
|
| Stroke | 2 | 2023 | 956 | 0.210 |
Why?
|
| Hearing Loss, Sensorineural | 1 | 2024 | 140 | 0.200 |
Why?
|
| Apyrase | 1 | 2022 | 18 | 0.200 |
Why?
|
| Spastic Paraplegia, Hereditary | 1 | 2022 | 29 | 0.200 |
Why?
|
| F-Box Proteins | 1 | 2022 | 34 | 0.200 |
Why?
|
| Calcium Channels, R-Type | 1 | 2021 | 2 | 0.200 |
Why?
|
| Rare Diseases | 1 | 2024 | 185 | 0.200 |
Why?
|
| RNA, Long Noncoding | 1 | 2024 | 210 | 0.200 |
Why?
|
| Craniosynostoses | 1 | 2024 | 131 | 0.190 |
Why?
|
| Coat Protein Complex I | 1 | 2021 | 14 | 0.190 |
Why?
|
| Coatomer Protein | 1 | 2021 | 30 | 0.190 |
Why?
|
| Brain Diseases | 2 | 2021 | 296 | 0.190 |
Why?
|
| Syndactyly | 1 | 2021 | 24 | 0.190 |
Why?
|
| Aniridia | 1 | 2021 | 12 | 0.190 |
Why?
|
| Phosphoprotein Phosphatases | 1 | 2022 | 115 | 0.190 |
Why?
|
| Calcium Channels, L-Type | 1 | 2021 | 53 | 0.190 |
Why?
|
| Inositol 1,4,5-Trisphosphate Receptors | 1 | 2021 | 35 | 0.190 |
Why?
|
| Muscle Hypotonia | 4 | 2024 | 186 | 0.190 |
Why?
|
| Cation Transport Proteins | 1 | 2021 | 99 | 0.180 |
Why?
|
| Migraine with Aura | 1 | 2021 | 16 | 0.180 |
Why?
|
| Dwarfism | 1 | 2021 | 102 | 0.180 |
Why?
|
| Hemiplegia | 1 | 2021 | 40 | 0.180 |
Why?
|
| Calcineurin | 1 | 2021 | 100 | 0.180 |
Why?
|
| Movement Disorders | 1 | 2023 | 221 | 0.180 |
Why?
|
| Alternative Splicing | 1 | 2023 | 346 | 0.180 |
Why?
|
| Dystonic Disorders | 1 | 2021 | 81 | 0.180 |
Why?
|
| Pedigree | 5 | 2024 | 1577 | 0.180 |
Why?
|
| Exons | 3 | 2018 | 793 | 0.180 |
Why?
|
| Sodium-Potassium-Exchanging ATPase | 1 | 2021 | 98 | 0.180 |
Why?
|
| Long QT Syndrome | 1 | 2021 | 86 | 0.180 |
Why?
|
| Tremor | 1 | 2021 | 129 | 0.180 |
Why?
|
| Osteoporosis | 1 | 2021 | 114 | 0.180 |
Why?
|
| Proteomics | 1 | 2024 | 476 | 0.180 |
Why?
|
| Thymidine Phosphorylase | 1 | 2020 | 12 | 0.180 |
Why?
|
| Dietary Supplements | 2 | 2016 | 456 | 0.180 |
Why?
|
| Matrix Attachment Region Binding Proteins | 1 | 2020 | 18 | 0.180 |
Why?
|
| Introns | 1 | 2021 | 302 | 0.180 |
Why?
|
| Scoliosis | 1 | 2021 | 134 | 0.170 |
Why?
|
| Infant, Newborn, Diseases | 1 | 2022 | 174 | 0.170 |
Why?
|
| eIF-2 Kinase | 1 | 2020 | 37 | 0.170 |
Why?
|
| Syndrome | 5 | 2024 | 1122 | 0.170 |
Why?
|
| Karyotyping | 1 | 2020 | 338 | 0.170 |
Why?
|
| Bone and Bones | 1 | 2021 | 262 | 0.160 |
Why?
|
| Cohort Studies | 4 | 2024 | 4643 | 0.160 |
Why?
|
| Hospice and Palliative Care Nursing | 1 | 2019 | 18 | 0.160 |
Why?
|
| Neural Cell Adhesion Molecule L1 | 1 | 2018 | 6 | 0.160 |
Why?
|
| Pediatric Nursing | 1 | 2019 | 39 | 0.160 |
Why?
|
| Chromosomal Instability | 1 | 2019 | 58 | 0.160 |
Why?
|
| Physical Examination | 1 | 2020 | 163 | 0.160 |
Why?
|
| Neurons | 3 | 2024 | 1924 | 0.160 |
Why?
|
| Iron | 1 | 2021 | 263 | 0.160 |
Why?
|
| Pigmentation Disorders | 1 | 2018 | 23 | 0.160 |
Why?
|
| 1-Alkyl-2-acetylglycerophosphocholine Esterase | 1 | 2018 | 87 | 0.160 |
Why?
|
| 14-3-3 Proteins | 1 | 2018 | 54 | 0.160 |
Why?
|
| Phosphotransferases (Alcohol Group Acceptor) | 1 | 2018 | 73 | 0.160 |
Why?
|
| Malformations of Cortical Development | 1 | 2018 | 53 | 0.160 |
Why?
|
| Megalencephaly | 1 | 2018 | 58 | 0.160 |
Why?
|
| Osteochondrodysplasias | 1 | 2019 | 68 | 0.150 |
Why?
|
| Young Adult | 7 | 2024 | 8800 | 0.150 |
Why?
|
| Early Diagnosis | 1 | 2019 | 178 | 0.150 |
Why?
|
| Nonsense Mediated mRNA Decay | 1 | 2018 | 29 | 0.150 |
Why?
|
| Noonan Syndrome | 1 | 2018 | 29 | 0.150 |
Why?
|
| Sleep Wake Disorders | 1 | 2020 | 173 | 0.150 |
Why?
|
| CDC2 Protein Kinase | 1 | 2017 | 35 | 0.150 |
Why?
|
| Molecular Chaperones | 1 | 2018 | 169 | 0.140 |
Why?
|
| Common Data Elements | 1 | 2017 | 6 | 0.140 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2018 | 244 | 0.140 |
Why?
|
| Hernias, Diaphragmatic, Congenital | 1 | 2022 | 383 | 0.140 |
Why?
|
| Point Mutation | 2 | 2017 | 346 | 0.140 |
Why?
|
| Calcium Channels | 1 | 2017 | 160 | 0.140 |
Why?
|
| NF-kappa B | 1 | 2019 | 462 | 0.130 |
Why?
|
| Fetus | 2 | 2023 | 579 | 0.130 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2018 | 428 | 0.130 |
Why?
|
| Face | 1 | 2017 | 181 | 0.130 |
Why?
|
| Congenital Abnormalities | 1 | 2018 | 242 | 0.130 |
Why?
|
| Rhabdomyolysis | 1 | 2016 | 35 | 0.130 |
Why?
|
| DNA Damage | 1 | 2019 | 517 | 0.130 |
Why?
|
| Nuclear Proteins | 1 | 2022 | 1282 | 0.130 |
Why?
|
| Prenatal Diagnosis | 2 | 2023 | 581 | 0.130 |
Why?
|
| Dopa Decarboxylase | 1 | 2015 | 7 | 0.130 |
Why?
|
| Aromatic-L-Amino-Acid Decarboxylases | 1 | 2015 | 17 | 0.120 |
Why?
|
| Ribonucleoprotein, U5 Small Nuclear | 1 | 2015 | 5 | 0.120 |
Why?
|
| Peptide Elongation Factors | 1 | 2015 | 12 | 0.120 |
Why?
|
| Muscle Weakness | 1 | 2016 | 82 | 0.120 |
Why?
|
| Mandibulofacial Dysostosis | 1 | 2015 | 14 | 0.120 |
Why?
|
| Chronic Disease | 1 | 2019 | 1166 | 0.120 |
Why?
|
| RNA, Transfer, Leu | 1 | 2014 | 6 | 0.120 |
Why?
|
| Abnormalities, Multiple | 2 | 2024 | 973 | 0.120 |
Why?
|
| Genes, Mitochondrial | 1 | 2014 | 17 | 0.120 |
Why?
|
| Amino Acid Metabolism, Inborn Errors | 1 | 2015 | 101 | 0.110 |
Why?
|
| Class I Phosphatidylinositol 3-Kinases | 1 | 2014 | 73 | 0.110 |
Why?
|
| Sequence Analysis, DNA | 1 | 2020 | 1759 | 0.110 |
Why?
|
| Proteins | 1 | 2019 | 1042 | 0.110 |
Why?
|
| Genome, Human | 2 | 2017 | 1261 | 0.110 |
Why?
|
| Nerve Tissue Proteins | 1 | 2019 | 1113 | 0.110 |
Why?
|
| Exome | 4 | 2022 | 1041 | 0.110 |
Why?
|
| Diagnosis, Differential | 1 | 2018 | 1871 | 0.110 |
Why?
|
| Mutation, Missense | 3 | 2024 | 844 | 0.100 |
Why?
|
| Mental Disorders | 1 | 2019 | 821 | 0.100 |
Why?
|
| Practice Guidelines as Topic | 1 | 2019 | 1243 | 0.100 |
Why?
|
| DNA Copy Number Variations | 1 | 2017 | 942 | 0.100 |
Why?
|
| Arrhythmias, Cardiac | 1 | 2016 | 457 | 0.100 |
Why?
|
| Metabolomics | 1 | 2015 | 396 | 0.100 |
Why?
|
| Haploinsufficiency | 2 | 2024 | 248 | 0.100 |
Why?
|
| Liver Transplantation | 1 | 2020 | 1033 | 0.090 |
Why?
|
| Genotype | 3 | 2024 | 2534 | 0.090 |
Why?
|
| Adult | 10 | 2024 | 28725 | 0.090 |
Why?
|
| Polymorphism, Single Nucleotide | 2 | 2018 | 2581 | 0.090 |
Why?
|
| Pregnancy | 2 | 2023 | 7103 | 0.090 |
Why?
|
| Glucose | 1 | 2014 | 876 | 0.080 |
Why?
|
| Severity of Illness Index | 3 | 2024 | 2813 | 0.080 |
Why?
|
| Protein Isoforms | 2 | 2023 | 410 | 0.080 |
Why?
|
| Homozygote | 2 | 2024 | 534 | 0.080 |
Why?
|
| Golgi Apparatus | 2 | 2021 | 92 | 0.080 |
Why?
|
| Whole Genome Sequencing | 2 | 2021 | 285 | 0.070 |
Why?
|
| Animals | 7 | 2023 | 33865 | 0.070 |
Why?
|
| Zebrafish | 2 | 2021 | 380 | 0.070 |
Why?
|
| Gene Deletion | 2 | 2024 | 798 | 0.070 |
Why?
|
| United States | 4 | 2024 | 10467 | 0.070 |
Why?
|
| Endoplasmic Reticulum Stress | 2 | 2018 | 122 | 0.070 |
Why?
|
| DNA Mutational Analysis | 2 | 2021 | 793 | 0.070 |
Why?
|
| Diabetes Mellitus | 1 | 2014 | 838 | 0.070 |
Why?
|
| Heart Defects, Congenital | 1 | 2017 | 1802 | 0.060 |
Why?
|
| SAM Domain and HD Domain-Containing Protein 1 | 1 | 2024 | 4 | 0.060 |
Why?
|
| Ribonuclease H | 1 | 2024 | 5 | 0.060 |
Why?
|
| Interferon-Induced Helicase, IFIH1 | 1 | 2024 | 13 | 0.060 |
Why?
|
| Mice | 4 | 2023 | 17613 | 0.060 |
Why?
|
| Exodeoxyribonucleases | 1 | 2024 | 49 | 0.060 |
Why?
|
| Cerebroside-Sulfatase | 1 | 2024 | 6 | 0.060 |
Why?
|
| Chloride-Bicarbonate Antiporters | 1 | 2023 | 8 | 0.060 |
Why?
|
| Sodium-Bicarbonate Symporters | 1 | 2023 | 14 | 0.060 |
Why?
|
| Nitric Oxide Donors | 1 | 2023 | 23 | 0.060 |
Why?
|
| MAP Kinase Kinase Kinases | 1 | 2024 | 48 | 0.060 |
Why?
|
| Genes, Recessive | 1 | 2024 | 171 | 0.060 |
Why?
|
| Deafness | 1 | 2024 | 80 | 0.060 |
Why?
|
| Bicarbonates | 1 | 2023 | 98 | 0.060 |
Why?
|
| Mice, Knockout | 2 | 2023 | 3771 | 0.050 |
Why?
|
| Sodium Bicarbonate | 1 | 2023 | 52 | 0.050 |
Why?
|
| Neurologists | 1 | 2023 | 17 | 0.050 |
Why?
|
| Limb Deformities, Congenital | 1 | 2024 | 105 | 0.050 |
Why?
|
| Drosophila melanogaster | 2 | 2019 | 737 | 0.050 |
Why?
|
| RNA, Small Nuclear | 1 | 2023 | 42 | 0.050 |
Why?
|
| Protein Structure, Secondary | 1 | 2023 | 239 | 0.050 |
Why?
|
| Amitriptyline | 1 | 2022 | 27 | 0.050 |
Why?
|
| Fetal Development | 1 | 2024 | 110 | 0.050 |
Why?
|
| Phosphoproteins | 1 | 2024 | 401 | 0.050 |
Why?
|
| Membrane Transport Proteins | 1 | 2023 | 175 | 0.050 |
Why?
|
| Gait | 1 | 2023 | 143 | 0.050 |
Why?
|
| Sodium | 1 | 2023 | 290 | 0.050 |
Why?
|
| Dysarthria | 1 | 2022 | 21 | 0.050 |
Why?
|
| Base Sequence | 2 | 2018 | 3118 | 0.050 |
Why?
|
| Sequence Deletion | 1 | 2024 | 526 | 0.050 |
Why?
|
| Glutathione | 1 | 2023 | 198 | 0.050 |
Why?
|
| Neonatal Screening | 1 | 2024 | 187 | 0.050 |
Why?
|
| Transposases | 1 | 2022 | 40 | 0.050 |
Why?
|
| KCNQ2 Potassium Channel | 1 | 2022 | 40 | 0.050 |
Why?
|
| Separase | 1 | 2022 | 29 | 0.050 |
Why?
|
| Signal Transduction | 1 | 2014 | 4510 | 0.050 |
Why?
|
| Cataract | 1 | 2024 | 218 | 0.050 |
Why?
|
| Paraplegia | 1 | 2022 | 91 | 0.050 |
Why?
|
| Levodopa | 1 | 2021 | 89 | 0.050 |
Why?
|
| Prospective Studies | 2 | 2024 | 5971 | 0.050 |
Why?
|
| Ascorbic Acid | 1 | 2021 | 78 | 0.050 |
Why?
|
| Caenorhabditis elegans Proteins | 1 | 2022 | 89 | 0.050 |
Why?
|
| HeLa Cells | 1 | 2023 | 808 | 0.050 |
Why?
|
| Collagen Type I | 1 | 2021 | 110 | 0.050 |
Why?
|
| Embryo, Nonmammalian | 1 | 2021 | 142 | 0.050 |
Why?
|
| Membrane Proteins | 2 | 2019 | 1525 | 0.050 |
Why?
|
| Consensus | 1 | 2024 | 604 | 0.050 |
Why?
|
| Facies | 1 | 2021 | 155 | 0.050 |
Why?
|
| Symptom Assessment | 1 | 2021 | 96 | 0.050 |
Why?
|
| Caenorhabditis elegans | 1 | 2022 | 223 | 0.040 |
Why?
|
| Endoplasmic Reticulum | 1 | 2021 | 213 | 0.040 |
Why?
|
| Esophageal Motility Disorders | 1 | 2020 | 13 | 0.040 |
Why?
|
| Sleep Stages | 1 | 2020 | 30 | 0.040 |
Why?
|
| Thymidine | 1 | 2020 | 55 | 0.040 |
Why?
|
| Longitudinal Studies | 1 | 2024 | 1280 | 0.040 |
Why?
|
| Genetic Therapy | 1 | 2024 | 706 | 0.040 |
Why?
|
| RNA, Small Interfering | 1 | 2021 | 664 | 0.040 |
Why?
|
| Guanosine Diphosphate Fucose | 1 | 2018 | 3 | 0.040 |
Why?
|
| Guanosine Diphosphate Mannose | 1 | 2018 | 3 | 0.040 |
Why?
|
| Weight Gain | 1 | 2021 | 377 | 0.040 |
Why?
|
| Cross-Over Studies | 1 | 2020 | 303 | 0.040 |
Why?
|
| Gestational Age | 1 | 2023 | 1118 | 0.040 |
Why?
|
| Retrospective Studies | 3 | 2024 | 15856 | 0.040 |
Why?
|
| Fucosyltransferases | 1 | 2018 | 29 | 0.040 |
Why?
|
| Peripheral Nervous System Diseases | 1 | 2020 | 129 | 0.040 |
Why?
|
| Glycosylation | 1 | 2018 | 112 | 0.040 |
Why?
|
| Ataxia | 1 | 2020 | 168 | 0.040 |
Why?
|
| Cerebellum | 1 | 2022 | 411 | 0.040 |
Why?
|
| Drug Resistant Epilepsy | 1 | 2021 | 201 | 0.040 |
Why?
|
| Unfolded Protein Response | 1 | 2018 | 62 | 0.040 |
Why?
|
| Disease Progression | 1 | 2024 | 1992 | 0.040 |
Why?
|
| Ubiquitin | 1 | 2018 | 141 | 0.040 |
Why?
|
| Transcriptome | 1 | 2024 | 904 | 0.040 |
Why?
|
| Mutant Proteins | 1 | 2018 | 112 | 0.040 |
Why?
|
| Neuroglia | 1 | 2019 | 192 | 0.040 |
Why?
|
| Interferon Type I | 1 | 2018 | 107 | 0.040 |
Why?
|
| Craniofacial Abnormalities | 1 | 2019 | 243 | 0.040 |
Why?
|
| Frameshift Mutation | 1 | 2018 | 175 | 0.040 |
Why?
|
| Disease Management | 1 | 2021 | 511 | 0.040 |
Why?
|
| Amino Acid Substitution | 1 | 2018 | 390 | 0.040 |
Why?
|
| National Institute of Neurological Disorders and Stroke (U.S.) | 1 | 2017 | 8 | 0.040 |
Why?
|
| Immunophenotyping | 1 | 2018 | 332 | 0.040 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2017 | 119 | 0.040 |
Why?
|
| Reproducibility of Results | 1 | 2024 | 2793 | 0.040 |
Why?
|
| Sequence Alignment | 1 | 2018 | 623 | 0.040 |
Why?
|
| Behavior, Animal | 1 | 2019 | 477 | 0.030 |
Why?
|
| Case-Control Studies | 2 | 2016 | 3231 | 0.030 |
Why?
|
| Mosaicism | 1 | 2018 | 241 | 0.030 |
Why?
|
| Proteasome Endopeptidase Complex | 1 | 2018 | 279 | 0.030 |
Why?
|
| RNA Splicing | 1 | 2018 | 223 | 0.030 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2021 | 1007 | 0.030 |
Why?
|
| Genetic Linkage | 1 | 2018 | 450 | 0.030 |
Why?
|
| Muscle Proteins | 1 | 2019 | 416 | 0.030 |
Why?
|
| Gene Expression | 1 | 2021 | 1591 | 0.030 |
Why?
|
| Animals, Genetically Modified | 1 | 2017 | 315 | 0.030 |
Why?
|
| Immunologic Deficiency Syndromes | 1 | 2018 | 201 | 0.030 |
Why?
|
| Arabs | 1 | 2016 | 28 | 0.030 |
Why?
|
| Skin | 1 | 2018 | 506 | 0.030 |
Why?
|
| Dihydroxyphenylalanine | 1 | 2015 | 8 | 0.030 |
Why?
|
| Foscarnet | 1 | 1995 | 1 | 0.030 |
Why?
|
| Cytomegalovirus Retinitis | 1 | 1995 | 16 | 0.030 |
Why?
|
| Electroencephalography | 1 | 2020 | 860 | 0.030 |
Why?
|
| Data Collection | 1 | 2017 | 383 | 0.030 |
Why?
|
| Ganciclovir | 1 | 1995 | 105 | 0.030 |
Why?
|
| Family | 1 | 2018 | 568 | 0.030 |
Why?
|
| Tyrosine | 1 | 2015 | 166 | 0.030 |
Why?
|
| Pilot Projects | 1 | 2019 | 1364 | 0.030 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2017 | 551 | 0.030 |
Why?
|
| Neuroimaging | 1 | 2017 | 329 | 0.030 |
Why?
|
| Homeodomain Proteins | 1 | 2017 | 547 | 0.030 |
Why?
|
| Codon, Nonsense | 1 | 2015 | 131 | 0.030 |
Why?
|
| Isotope Labeling | 1 | 2014 | 102 | 0.030 |
Why?
|
| AIDS-Related Opportunistic Infections | 1 | 1995 | 139 | 0.030 |
Why?
|
| Amino Acid Sequence | 1 | 2018 | 2701 | 0.030 |
Why?
|
| Gluconeogenesis | 1 | 2014 | 107 | 0.030 |
Why?
|
| Drosophila Proteins | 1 | 2019 | 709 | 0.030 |
Why?
|
| Research Design | 1 | 2017 | 643 | 0.030 |
Why?
|
| Treatment Outcome | 2 | 2021 | 12016 | 0.030 |
Why?
|
| Cells, Cultured | 1 | 2019 | 3075 | 0.030 |
Why?
|
| Cell Line | 1 | 2018 | 2785 | 0.030 |
Why?
|
| Reactive Nitrogen Species | 1 | 2012 | 8 | 0.030 |
Why?
|
| Radiography | 1 | 2015 | 805 | 0.030 |
Why?
|
| Argininosuccinate Synthase | 1 | 2012 | 20 | 0.030 |
Why?
|
| Electron Transport Complex IV | 1 | 2012 | 41 | 0.030 |
Why?
|
| Electron Transport | 1 | 2012 | 54 | 0.030 |
Why?
|
| Argininosuccinate Lyase | 1 | 2012 | 60 | 0.020 |
Why?
|
| RNA, Messenger | 1 | 2018 | 2832 | 0.020 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 1 | 2020 | 1192 | 0.020 |
Why?
|
| Nitric Oxide Synthase Type III | 1 | 2012 | 221 | 0.020 |
Why?
|
| Biomedical Research | 1 | 2017 | 510 | 0.020 |
Why?
|
| Cross-Sectional Studies | 1 | 2019 | 3306 | 0.020 |
Why?
|
| Inflammation | 1 | 2018 | 1397 | 0.020 |
Why?
|
| Molecular Sequence Data | 1 | 2016 | 3887 | 0.020 |
Why?
|
| Genome-Wide Association Study | 1 | 2017 | 1633 | 0.020 |
Why?
|
| Insulin Resistance | 1 | 2014 | 629 | 0.020 |
Why?
|
| Insulin | 1 | 2014 | 1186 | 0.020 |
Why?
|
| Clinical Trials as Topic | 1 | 2012 | 1081 | 0.020 |
Why?
|
| Middle Aged | 2 | 2014 | 25564 | 0.010 |
Why?
|
| Prognosis | 1 | 2012 | 4479 | 0.010 |
Why?
|
| Drug Administration Schedule | 1 | 1995 | 728 | 0.010 |
Why?
|
| Drug Therapy, Combination | 1 | 1995 | 1146 | 0.010 |
Why?
|